|
LPIN1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
9.4323000521257E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62858615482264E-12 |
| Stage1-vs-Stage2 |
2.093400E-01 |
| Stage1-vs-Stage3 |
5.048000E-01 |
| Stage1-vs-Stage4 |
8.181800E-01 |
| Stage2-vs-Stage3 |
1.185770E-01 |
| Stage2-vs-Stage4 |
3.126000E-01 |
| Stage3-vs-Stage4 |
4.682200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.83749998234384E-09 |
| Normal-vs-Asian |
6.013700E-02 |
| Caucasian-vs-AfricanAmerican |
1.375730E-02 |
| Caucasian-vs-Asian |
2.510300E-02 |
| AfricanAmerican-vs-Asian |
3.019200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
7.699800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.70789999990262E-07 |
| Normal-vs-Age(41-60Yrs) |
1.62458935193399E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
<1E-12 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.686800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.366800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.360000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.509800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.098100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.077000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.74810005254744E-09 |
| Normal-vs-Grade 2 |
<1E-12 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.89903648362133E-12 |
| Grade 1-vs-Grade 2 |
9.689000E-01 |
| Grade 1-vs-Grade 3 |
8.851600E-01 |
| Grade 1-vs-Grade 4 |
5.551800E-01 |
| Grade 2-vs-Grade 3 |
6.134000E-01 |
| Grade 2-vs-Grade 4 |
2.489000E-01 |
| Grade 3-vs-Grade 4 |
1.156420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
1.04430020186896E-10 |
| ccA subtype-vs-ccB subtype |
8.8461016289898E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62458935193399E-12 |
| Normal-vs-N1 |
5.62490000000082E-05 |
| N0-vs-N1 |
5.080400E-01 |
|
|
